Follow The Filings

Scribe Therapeutics Inc.

Filed as SCRIBE THERAPEUTICS INC (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed

  • 2 Owners
  • Max 0.1%
  • $21M
  • 2 new

In 2026 Q3 Cathie Wood and Farallon Capital Management opened positions in Scribe Therapeutics.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Cathie Wood, ARK Investment Management). Not free-float ownership.

  1. Cathie Wood New 0.08%
  2. Farallon Capital Management New 0.03%

Holders

Sorted by value, long equity only, as of 2026 Q3.

History
Cathie Wood, ARK Investment Management 0.08% New 0.08% 786,921 $14M History
Farallon Capital Management 0.03% New 0.03% 380,000 $7M History

Weight bar: held both quarters added sold at this quarter’s reported price

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Period archive

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf